Valeant Rejected Takeda Bid

Reuters reports that Valeant Pharmaceuticals rejected a joint takeover offer from Japan's Takeda and TPG Capital Management this spring.

The offer was reportedly made a few weeks before Joseph Papa took over as Valeant's new chief executive in April.

More on the story here.